ClinicalTrials.Veeva

Menu

The Comparison of Low Thoracic Paravertebral Block Versus Peritubal Infiltration

A

Ataturk University

Status and phase

Completed
Phase 4

Conditions

Percutaneous Nephrolithotomy

Treatments

Device: Ultrasound
Drug: Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT02764008
AUTF ANESTHESIA2

Details and patient eligibility

About

Percutaneous nephrolithotomy (PCNL) is a safe and effective procedure that is considered the standard treatment for large and complex renal stones. Although it has lower complication and morbidity rates than open surgery, the pain and discomfort related to a nephrostomy tube can cause distress for patients.

Managing this pain with opioids can lead to sedation, nausea, vomiting, and constipation, which defeat the purpose of this minimally invasive procedure.

Skin infiltration with bupivacaine around the nephrostomy tube is not effective. Infiltration of renal capsule has shown to facilitate painless insertion of nephrostomy tube, suggesting the role of renal capsule in pain management.

Peritubal infiltration of bupivacaine from renal capsule to the skin along the nephrostomy tract may alleviate postoperative pain. A unilateral Low thoracic paravertebral (PVB) block offers the option of providing extendable perioperative pain relief without the above side effects or the physiologic derangement associated with local anesthetics in the central neuraxial space.

The aim of this study is to determine whether ultrasound guided low thoracic paravertebral block effective post-operative analgesia as compared to peritubal infiltration analgesia in patients undergoing percutaneous nephrolithotomy.

Main outcome measures: The primary endpoint is postoperative opioid consumption. Secondary endpoints are visual analogue pain scores, opioid related side effects.

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologist's physiologic state I-III patients undergoing percutaneous nephrolithotomy

Exclusion criteria

  • chronic pain
  • bleeding disorders
  • renal or hepatic insufficiency
  • patients on chronic non-steroidal anti-inflammatory medications
  • emergency cases

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 3 patient groups

Low thoracic paravertebral block
Active Comparator group
Description:
T8-T9 Ultrasound guided paravertebral block with 20 ml %0,25 bupivacaine
Treatment:
Device: Ultrasound
Drug: Bupivacaine
Peritubal infiltration
Active Comparator group
Description:
Peritubal infiltration with 20 ml %0,25 bupivacaine
Treatment:
Drug: Bupivacaine
Control Group
No Intervention group
Description:
No drug

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems